Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: A meta-analysis and systemic review - Chang, Y H; Chang, D M; Lin, K C (Diabetes Metab Res Rev, 2011)
et al.